We are live on
!
Find out more
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
KRTX
Delisted
KRTX was delisted on the 15th of March, 2024.
Fund managers haven’t disclosed any holdings of KRTX yet.
KRTX Hedge Fund Activity: Q2 2024 in Review
0 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Karuna Therapeutics, Inc. Common Stock (KRTX) for Q2 2024, worth a combined $0 — down 100% from $270K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of KRTX and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was IFP Advisors, exiting entirely with an estimated $269K sold.
- 0 institutional investors held Karuna Therapeutics, Inc. Common Stock (KRTX) as of Q2 2024, down from 2 in Q1 2024.
- Funds reported $0 of Karuna Therapeutics, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
- 0 funds opened new Karuna Therapeutics, Inc. Common Stock positions in Q2 2024 and 2 closed out, a net change of -2 holders.
- The largest Karuna Therapeutics, Inc. Common Stock seller in Q2 2024 was IFP Advisors, an estimated $269K sold.
Based on aggregated 13F filings for Q2 2024.